Outset Medical Stock Forecast

OM's stock price has decreased by -63.71% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Outset Medical stock have an average target of 60, with a low estimate of 45 and a high estimate of 90. The average target predicts an increase of 419.03% from the current stock price of 11.56.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$45	$60	$45	$90
Change	+289.27%	+419.03%	+289.27%	+678.55%

* Price targets were last updated on Jan 7, 2025.

Analyst Ratings

The average analyst rating for Outset Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	3	3	3	2	2	2
Buy	0	0	0	0	0	0
Hold	3	3	3	1	1	1
Sell	1	1	1	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Shagun Singh RBC Capital	RBC Capital	Hold Reiterates $45	Hold	Reiterates	$45	+289.27%	Jan 7, 2025
Shagun Singh RBC Capital	RBC Capital	Buy → Hold Downgrades $90 → $45	Buy → Hold	Downgrades	$90 → $45	+289.27%	Aug 8, 2024
Joshua Jennings TD Cowen	TD Cowen	Strong Buy Maintains $135 → $45	Strong Buy	Maintains	$135 → $45	+289.27%	Aug 8, 2024
Shagun Singh RBC Capital	RBC Capital	Hold → Buy Upgrades $75 → $90	Hold → Buy	Upgrades	$75 → $90	+678.55%	Jun 21, 2024
Maria Thibault BTIG	BTIG	Strong Buy Initiates $90	Strong Buy	Initiates	$90	+678.55%	Apr 8, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

123.90M

from 113.69M

8.98%

from 113.69M

Revenue Next Year

139.69M

from 123.90M

12.74%

from 123.90M

EPS This Year

-8.45

from -36.95

EPS Next Year

-9.30

from -8.45

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	49.94M	102.60M	115.38M	130.38M	113.69M	123.90M	139.69M	159.14M
Revenue Growth	231.18%	105.47%	12.45%	13.00%	-12.80%	8.98%	12.74%	13.92%
EPS	-72.74	-43.41	-50.75	-52.27	-36.95	-8.45	-9.30	-9.66
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	126.8M	147.0M	170.0M
Avg	123.9M	139.7M	159.1M
Low	117.6M	129.9M	144.2M

Revenue Growth

Revenue Growth	2025	2026	2027
High	11.6%	18.6%	21.7%
Avg	9.0%	12.7%	13.9%
Low	3.4%	4.8%	3.2%

EPS Forecast

EPS	2025	2026	2027
High	-3.15	-2.21	-1.42
Avg	-8.45	-9.30	-9.66
Low	-19.26	-18.96	-17.05

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.